71 related articles for article (PubMed ID: 11411202)
21. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic testing in hepatitis C virus infection: viral kinetics and genomics.
Pawlotsky JM
Semin Liver Dis; 2003; 23 Suppl 1():3-11. PubMed ID: 12934162
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
24. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis.
Kaiser T; Damerow HC; Tenckhoff S; Finger A; Böttcher I; Hafer C; Schwarz A; Lüth JB; Schmidt Gürtler H; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
J Med Virol; 2008 Jul; 80(7):1195-201. PubMed ID: 18461613
[TBL] [Abstract][Full Text] [Related]
26. Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
J Med Virol; 2009 Aug; 81(8):1354-62. PubMed ID: 19551828
[TBL] [Abstract][Full Text] [Related]
27. Virology and pathogenesis of hepatitis C virus recurrence.
Ramírez S; Pérez-Del-Pulgar S; Forns X
Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
[TBL] [Abstract][Full Text] [Related]
28. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
[TBL] [Abstract][Full Text] [Related]
29. Cell culture and infection system for hepatitis C virus.
Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
[TBL] [Abstract][Full Text] [Related]
30. Novel insights into hepatitis C virus replication and persistence.
Bartenschlager R; Frese M; Pietschmann T
Adv Virus Res; 2004; 63():71-180. PubMed ID: 15530561
[TBL] [Abstract][Full Text] [Related]
31. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
[TBL] [Abstract][Full Text] [Related]
32. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
Xu DZ; Xie Y; Li ZQ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
[TBL] [Abstract][Full Text] [Related]
33. Course and outcome of hepatitis C.
Hoofnagle JH
Hepatology; 2002 Nov; 36(5 Suppl 1):S21-9. PubMed ID: 12407573
[TBL] [Abstract][Full Text] [Related]
34. Host cell responses induced by hepatitis C virus binding.
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
[TBL] [Abstract][Full Text] [Related]
35. Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance.
Shekhtman L; Navasa M; Sansone N; Crespo G; Subramanya G; Chung TL; Cardozo-Ojeda EF; Pérez-Del-Pulgar S; Perelson AS; Cotler SJ; Forns X; Uprichard SL; Dahari H
Elife; 2021 Nov; 10():. PubMed ID: 34730511
[TBL] [Abstract][Full Text] [Related]
36. HCV Spread Kinetics Reveal Varying Contributions of Transmission Modes to Infection Dynamics.
Durso-Cain K; Kumberger P; Schälte Y; Fink T; Dahari H; Hasenauer J; Uprichard SL; Graw F
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372514
[TBL] [Abstract][Full Text] [Related]
37. [Entry mechanisms of HCV].
Tani H; Matsuura Y
Nihon Rinsho; 2011 May; 69 Suppl 4():47-51. PubMed ID: 22096892
[No Abstract] [Full Text] [Related]
38. Mathematical Analysis of a Transformed ODE from a PDE Multiscale Model of Hepatitis C Virus Infection.
Kitagawa K; Kuniya T; Nakaoka S; Asai Y; Watashi K; Iwami S
Bull Math Biol; 2019 May; 81(5):1427-1441. PubMed ID: 30644067
[TBL] [Abstract][Full Text] [Related]
39. Acute hepatitis C complicated by pancreatitis: another extrahepatic manifestation of hepatitis C virus?
Alvares-Da-Silva MR; Francisconi CF; Waechter FL
J Viral Hepat; 2000 Jan; 7(1):84-6. PubMed ID: 10718948
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C: a mouse at the end of the tunnel.
Binder M; Bartenschlager R
Cell Res; 2013 Dec; 23(12):1343-4. PubMed ID: 24060850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
